FDA NDC Directory · JSON-LD · Markdown

Cephalexin

NDC 59651-322 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA213568
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCEPHALEXIN (125 mg/5mL)
Marketing started20260609
Package count2

External sources

Source: openFDA. Public-domain (CC0).